Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Same author

Chronic Pruritus: A Review.

JAMA·2024

Same author

A hypopigmented and enlarging granulomatous eruption.

JAAD case reports·2024

Same author

Prospective observational pilot study of quantitative light dosimetry in erythropoietic protoporphyria.

Journal of the American Academy of Dermatology·2022

Same author

Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.

JAAD international·2022

Same author

Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.

Allergy·2022

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Hyperimmunoglobulin E syndrome with a novel STAT3 mutation.

Robert Anolik¹, Sarina Elmariah, Stephanie Lehrhoff

¹Department of Dermatology, New York University, USA.

Dermatology Online Journal

|November 7, 2009

Summary

This summary is machine-generated.

A patient with severe eczema and recurrent infections was diagnosed with Hyperimmunoglobulin E syndrome. A novel mutation in the STAT3 gene was identified as the cause.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Jun 19, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Area of Science:

Immunology
Genetics
Dermatology

Background:

Hyperimmunoglobulin E syndrome (HIES) is a primary immunodeficiency characterized by severe eczema, recurrent infections, and elevated IgE levels.
STAT3 mutations are a common cause of autosomal dominant HIES, leading to impaired immune cell function.

Observation:

A 35-year-old male presented with severe eczematous dermatitis, recurrent staphylococcal infections, and other significant medical issues.
Laboratory results revealed marked eosinophilia (2,400 cells/ml) and extremely high IgE levels (17,028 IU/mL).

Findings:

The patient was diagnosed with Hyperimmunoglobulin E syndrome based on clinical presentation and laboratory findings.
Genetic analysis identified a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (c.1123A>G) in intron 12, upstream of exon 13.

Implications:

This case highlights a new STAT3 mutation associated with Hyperimmunoglobulin E syndrome, expanding the known genetic spectrum of the disorder.
Understanding the specific mutation's impact on STAT3 function may lead to targeted therapies for HIES patients.
Early genetic diagnosis and management are crucial for improving outcomes in patients with primary immunodeficiencies like HIES.